NASSA, Giovanni
 Distribuzione geografica
Continente #
AS - Asia 7.207
NA - Nord America 5.145
EU - Europa 1.892
SA - Sud America 313
Continente sconosciuto - Info sul continente non disponibili 289
AF - Africa 64
OC - Oceania 6
Totale 14.916
Nazione #
HK - Hong Kong 5.299
US - Stati Uniti d'America 5.033
SG - Singapore 865
IT - Italia 806
CN - Cina 421
RU - Federazione Russa 241
BR - Brasile 238
VN - Vietnam 235
DE - Germania 202
UA - Ucraina 130
IE - Irlanda 83
FR - Francia 82
TR - Turchia 81
SE - Svezia 72
CA - Canada 69
IN - India 69
GB - Regno Unito 67
KR - Corea 67
FI - Finlandia 61
NL - Olanda 40
BD - Bangladesh 33
JP - Giappone 33
MX - Messico 27
PL - Polonia 27
AR - Argentina 26
AT - Austria 19
IQ - Iraq 18
SA - Arabia Saudita 18
ZA - Sudafrica 18
CO - Colombia 13
ES - Italia 13
CZ - Repubblica Ceca 12
MA - Marocco 12
UZ - Uzbekistan 12
VE - Venezuela 10
ID - Indonesia 9
PH - Filippine 9
PK - Pakistan 9
EC - Ecuador 8
CL - Cile 5
EG - Egitto 5
KE - Kenya 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
HU - Ungheria 4
KZ - Kazakistan 4
LV - Lettonia 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AU - Australia 3
BE - Belgio 3
CH - Svizzera 3
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
HR - Croazia 3
IL - Israele 3
JO - Giordania 3
MY - Malesia 3
PE - Perù 3
AL - Albania 2
BH - Bahrain 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
LT - Lituania 2
LY - Libia 2
OM - Oman 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AG - Antigua e Barbuda 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CD - Congo 1
CG - Congo 1
CR - Costa Rica 1
CV - Capo Verde 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GM - Gambi 1
GT - Guatemala 1
HN - Honduras 1
KI - Kiribati 1
LB - Libano 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
MU - Mauritius 1
Totale 14.619
Città #
Hong Kong 5.292
Ann Arbor 752
Dallas 650
San Jose 520
Singapore 475
Chandler 369
Ashburn 320
Woodbridge 252
Milan 225
Princeton 200
Jacksonville 170
Houston 156
Wilmington 156
Beijing 112
Salerno 93
Council Bluffs 85
The Dalles 85
Munich 84
Dublin 78
Lauterbourg 67
Santa Clara 65
Ho Chi Minh City 63
Los Angeles 62
Naples 56
Rome 56
New York 52
Hanoi 49
Izmir 49
Andover 42
Nanjing 38
Dearborn 37
Boardman 34
Moscow 33
Tokyo 33
Dong Ket 32
Montreal 30
São Paulo 26
Pellezzano 25
Turku 25
Warsaw 24
Fairfield 23
Memphis 23
Frankfurt am Main 20
Orem 20
Shenyang 20
Atlanta 19
Figino 19
Chicago 18
Nuremberg 18
Fisciano 17
London 17
Stockholm 17
Amsterdam 16
Changsha 16
Columbus 16
Denver 15
Mercato San Severino 15
Washington 15
Brooklyn 13
Nürnberg 13
Poplar 13
Seattle 13
Boston 12
Hebei 12
Phoenix 12
San Francisco 12
Brno 11
Jinan 11
Chennai 10
Da Nang 10
Düsseldorf 10
Guangzhou 10
Turin 10
Vienna 10
Ankara 9
Mexico City 9
Redwood City 9
Sarno 9
Seoul 9
Tashkent 9
Falls Church 8
Helsinki 8
Johannesburg 8
Norwalk 8
Rio de Janeiro 8
Tianjin 8
Zhengzhou 8
Bogotá 7
Buffalo 7
Calgary 7
Charlotte 7
Jeddah 7
New Delhi 7
Renton 7
Riyadh 7
Toronto 7
Baghdad 6
Bologna 6
Haiphong 6
Manchester 6
Totale 11.675
Nome #
Small non-coding RNA deregulation in endometrial carcinogenesis 1.123
The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei 722
Molecular mechanisms of selective estrogen receptor modulator activity in human breast cancer cells: Identification of novel nuclear cofactors of antiestrogen-ERα complexes by interaction proteomics. 553
Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer 505
Global View of Candidate Therapeutic Target Genes in Hormone-Responsive Breast Cancer 499
WIND (Workflow for pIRNAs aNd beyonD): a strategy for in-depth analysis of small RNA-seq data 496
Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis 480
Host nasopharyngeal transcriptome dataset of a SARS-CoV-2 positive Italian cohort 457
Suppression of Spry1 reduces HIF1α-dependent glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanoma 402
Small non-coding RNA transcriptomic profiling in adult and fetal human brain 337
Essential gene screening identifies the bromodomain-containing protein BRPF1 as a new actionable target for endocrine therapy-resistant breast cancers 252
Small Non-Coding RNA Profiling Identifies miR-181a-5p as a Mediator of Estrogen Receptor Beta-Induced Inhibition of Cholesterol Biosynthesis in Triple-Negative Breast Cancer 241
Identification of cytoplasmic proteins interacting with unliganded estrogen receptor α and β in human breast cancer cells 224
Splicing of platelet resident pre-mRNAs upon activation by physiological stimuli results in functionally relevant proteome modifications. 224
iSmaRT: a toolkit for a comprehensive analysis of small RNA-Seq data 206
The nuclear receptor ERβ engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading 204
Non-coding RNA profiling in BRaFV600E-mutant cutaneous melanoma before and after Spry1 depletion 200
Small RNA profiling reveals deregulated PTEN/PI3K/Akt pathway in asthmatic bronchial smooth muscle cells. 194
Effects of Oestrogen on MicroRNA Expression in Hormone-Responsive Breast Cancer Cells 193
Activating stimuli induce platelet microRNA modulation and proteome reorganisation 192
Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies 186
Whole-Exome Sequencing Revealed New Candidate Genes for Human Dilated Cardiomyopathy 181
A large set of estrogen receptor beta-interacting proteins identified by tandem affinity purification in hormone-responsive human breast cancer cells nuclei. 180
Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer. 178
Comparative analysis of nuclear estrogen receptor alpha and beta interactomes in breast cancer cells. 173
Global Analysis of Estrogen Receptor Beta Binding to Breast Cancer Cell Genome Reveals Extensive Interplay with Estrogen Receptor Alpha for Target Gene Regulation. 172
Phenytoin neurotoxicity in a child carrying new STXBP1 and CYP2C9 gene mutations. 172
Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells 167
Glucose Deprivation Promotes Pseudohypoxia and Dedifferentiation in Lung Adenocarcinoma 166
Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma 166
Global gene expression profile of normal and regenerating liver in young and old mice 164
Carcinogenic risk and Bisphenol A exposure: A focus on molecular aspects in endoderm derived glands 155
Atrial myxomas arise from multipotent cardiac stem cells 153
Identification of a hormone-regulated dynamic actin network associated with estrogen receptor alpha in human breast cancer cell nuclei. 151
Single-cell states in the estrogen response of breast cancer cell lines. 151
Large-scale profiling of signalling pathways reveals an asthma specific signature in bronchial smooth muscle cells 150
Timed regulation of P-Element-Induced Wimpy Testis-interacting RNA expression during rat liver regeneration. 147
New Insights on Estrogen Receptor Actions in Hormone-responsive Breast Cancer Cells by Interaction Proteomics 146
Global transcriptome profiles of Italian Mediterranean buffalo embryos with normal and retarded growth. 143
Post-transcriptional regulation of human breast cancer cell proteome by unliganded Estrogen Receptor beta via microRNAs. 143
Interaction Proteomics Identifies ERbeta Association with Chromatin Repressive Complexes to Inhibit Cholesterol Biosynthesis and Exert An Oncosuppressive Role in Triple-negative Breast Cancer 142
MicroRNA (miRNA) and piwi-interacting RNA (piRNA) signature of human primary bronchial epithelial cells (PBEC) after exposure to mainstream cigarette smoke (MCS) 142
iMir: an integrated pipeline for high-throughput analysis of small non-coding RNA data obtained by smallRNA-Seq. 141
The "busy life" of unliganded estrogen receptors 139
Quantitative mapping of RNA-mediated nuclear Estrogen Receptor β interactome in human breast cancer cells 139
Expression of functional tissue factor in activated T-lymphocytes in vitro and in vivo: A possible contribution of immunity to thrombosis? 136
Histone Methyltransferase DOT1L as a Promising Epigenetic Target for Treatment of Solid Tumors 134
RNA sequencing identifies specific PIWI-interacting small non-coding RNA expression patterns in breast cancer. 133
Identification of long non‑coding RNA expression patterns useful for molecular‑based classification of type I endometrial cancers 133
Identification of proteins associated with ligand-activated estrogen receptor alpha in human breast cancer cell nuclei by tandem affinity purification and nanoLC-MS/MS. 132
Inhibition of histone methyltransferase DOT1L silences ER gene and blocks proliferation of antiestrogen-resistant breast cancer cells 124
PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach 121
Molecular and Functional Characterization of the Somatic PIWIL1/piRNA Pathway in Colorectal Cancer Cells 120
An overview of candidate therapeutic target genes in ovarian cancer 120
HOME-BIO (sHOtgun MEtagenomic analysis of BIOlogical entities): a specific and comprehensive pipeline for metagenomic shotgun sequencing data analysis 120
Identification of Antiestrogen-Bound Estrogen Receptor α Interactomes in Hormone-Responsive Human Breast Cancer Cell Nuclei 116
Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer 113
Lack of pathogenic mutations in six patients with MMPSI. 110
Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes 108
TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness 108
Metabolic Regulation of Epigenetic Modifications and Cell Differentiation in Cancer 106
LncRNA PVT1 links estrogen receptor alpha and the polycomb repressive complex 2 in suppression of pro-apoptotic genes in hormone-responsive breast cancer 102
Transcriptomic profiling of calcified aortic valves in clonal hematopoiesis of indeterminate potential carriers 99
Whole Genome Sequence Dataset of Mycobacterium tuberculosis Strains from Patients of Campania Region 98
BRPF1 inhibition reduces migration and invasion of metastatic ovarian cancer cells, representing a potential therapeutic target 94
KCTD15 is overexpressed in human childhood B-cell acute lymphoid leukemia 94
Regulation of metabolic reprogramming by long non-coding rnas in cancer 93
rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC 90
Genome-wide DNA methylation changes upon DOT1L inhibition in hormone-responsive breast cancer cells 88
The Histone Methyltransferase DOT1L Is a Functional Component of Estrogen Receptor Alpha Signaling in Ovarian Cancer Cells 86
BRPF1 in cancer epigenetics: a key regulator of histone acetylation and a promising therapeutic target 82
Functional Relationships between Long Non-Coding RNAs and Estrogen Receptor Alpha: A New Frontier in Hormone-Responsive Breast Cancer Management 82
Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer 81
Caratterizzazione genomica e trascrittomica di tumori neuroendocrini gastro-enteropancreatici 74
RIZ2 at the crossroad of the EGF/EGFR signaling in colorectal cancer 68
Castalin Induces ROS Production, Leading to DNA Damage and Increasing the Activity of CHK1 Inhibitor in Cancer Cell Lines 54
Epigenetic alterations of AKT1 orchestrate a metabolic reprogramming in advanced lipedema: translational insights from an integrated multi-omics study 26
Identification of LncRNAs scaffolding a chromatin-associated gene regulatory complex in breast cancer cells comprising ERα, DOT1L and menin 16
Editorial: Chromatin modifications and gene expression: from mechanisms to therapeutic implications in disease 4
Totale 14.916
Categoria #
all - tutte 39.642
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.642


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022365 0 0 5 1 34 6 3 9 48 42 56 161
2022/2023819 62 94 37 113 79 129 10 96 131 6 44 18
2023/2024424 30 42 34 16 31 74 59 14 9 23 20 72
2024/20251.189 20 11 7 37 80 132 233 87 195 73 176 138
2025/20269.446 837 2.521 2.878 351 534 267 576 113 418 451 119 381
2026/2027239 193 46 0 0 0 0 0 0 0 0 0 0
Totale 14.916